JP2005179331A - Skin preparation for external use - Google Patents

Skin preparation for external use Download PDF

Info

Publication number
JP2005179331A
JP2005179331A JP2003436788A JP2003436788A JP2005179331A JP 2005179331 A JP2005179331 A JP 2005179331A JP 2003436788 A JP2003436788 A JP 2003436788A JP 2003436788 A JP2003436788 A JP 2003436788A JP 2005179331 A JP2005179331 A JP 2005179331A
Authority
JP
Japan
Prior art keywords
skin
mineral
external preparation
emits
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003436788A
Other languages
Japanese (ja)
Inventor
Tadashi Fukiya
忠 吹谷
Yasutaka Sakamoto
泰孝 坂本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2003436788A priority Critical patent/JP2005179331A/en
Publication of JP2005179331A publication Critical patent/JP2005179331A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To simply and easily acquire a hormesis effect by low dose radiation in a daily life. <P>SOLUTION: The skin preparation for external use is developed by using ultrafine particles of ceramic comprising a rare mineral element ore radiating low dose radiation as a raw material to utilize the hormesis effect by low dose radiation as supported by many experiments. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、人体に対する放射線ホルミシス効果を簡便、容易に獲得することができる皮膚外用剤に関するものである。  The present invention relates to an external preparation for skin that can easily and easily acquire a radiation hormesis effect on a human body.

肩こり症状はストレスや疲労が溜まることで発症するが、これは酸素と栄養物の運搬者である血液循環作用が悪化し生理的代謝作用が低下することで老廃物が溜まり、この老廃物が筋肉の神経を刺激し痛みを出すことによるものである。
冷え症や寒いところにいると、人は自然に前かがみの姿勢で肩をすくめ、身体を固くしてしまう。また、このような姿勢をとらないまでも身体が冷えると血管が収縮して血行が悪くなってしまい肩こりの症状を発症する。
Stiff shoulder symptoms develop when stress and fatigue accumulate, but this is due to deterioration of blood circulation, which is a carrier of oxygen and nutrients, and a decrease in physiological metabolic effects. This is because it stimulates the nerves and causes pain.
When you are in a cold or cold place, people naturally shrug their shoulders in a leaning posture and make their bodies stiff. Even if the body does not take such a posture, when the body cools, the blood vessels contract and blood circulation worsens, causing symptoms of stiff shoulders.

一般に、肩こりの解消にはマッサージ、カイロプラクティクス、針灸、磁気貼付医療器、湿布剤など様々な解消法が単独或いは複合して用いられているがその療法の大部分は筋肉の緊張をほぐすことを第一の目的としている。  In general, various methods for relieving stiff shoulders, such as massage, chiropractics, needle acupuncture, magnetic adhesive medical devices, and poultices, are used alone or in combination, but most of the therapy is to relieve muscle tension. It is the first purpose.

放射線ホルミシスの効果は、例えば血管拡張作用をもつα−ANPホルモンや鎮痛作用をもつβ−エンドルフィン、血糖量調整作用をもつインスリンといったホルモンの分泌を増加し、生体の調整機能を高める効果があることが公知されている。  The effect of radiation hormesis is to increase the secretion of hormones, such as α-ANP hormone with vasodilatory effect, β-endorphin with analgesic action, and insulin with blood sugar level regulating action, and has the effect of enhancing the regulation function of the living body Is known.

その他、SODやGPxなどの抗酸化物質増加の効果や、生体防御機能の活性化効果、身体老化の抑制効果、がんの抑制効果、遺伝子損傷修復機構の活性化等の効果が公知されている。  Other effects such as the effect of increasing antioxidants such as SOD and GPx, the effect of activating the body defense function, the effect of suppressing body aging, the effect of suppressing cancer, and the activation of the gene damage repair mechanism are known. .

ラドン鉱石の放射線ホルミシス効果を臨床的に利用している例として、日本の三朝温泉のラドン濃度が2000Bq/立法mに対し、低線量放射線による医療行為を幅広く行っているオーストリアのバドガシュタインでは160000Bq/立法mの効能度である。  As an example of the clinical use of the radiation hormesis effect of radon ores, the radon concentration in Japan's Misasa hot springs is 2000 Bq / legal m. / Effectiveness of legislation m.

トルマリン鉱石は「電気石」と呼ばれる鉱物で、自らエネルギーを持つ鉱物の一つであり、唯一、自然の状態で永久的に電子を流し続ける鉱物である。
トルマリンの結晶の両端にはプラス極とマイナス極の永久電極を持ち、そこには0.06ミリアンペアの微弱電流が生じており人体のツボを刺激し体内に取り込まれ細胞を活性化することが公知されている。
Tourmaline ore is a mineral called “tourmaline”, one of the minerals that has its own energy, and the only mineral that continues to flow electrons permanently in its natural state.
It is known that there are positive and negative permanent electrodes at both ends of the tourmaline crystal, where a weak current of 0.06 milliamps is generated, stimulating the acupoints of the human body and taking them into the body to activate the cells. Has been.

トルマリンは周囲の熱エネルギーを一度蓄え「遠赤外線」に変換して放射する特性を持ち、その熱エネルギーの変換効率は92.72%(遠赤外線波長4〜11ミクロン)と抜群に高いことが公知されている。
特開2000−273033号公報 K.yamaokaほか、Arch.Bikphys;302.37(1993) G.Bernatzkyほか、Z.Phys.Med.B−aln.Med.Klin;19.36(1990) M.Mifuneほか、Jpn.J.Cancer R−es;83.1(1992)) Y.Suzukiほか、Jpn.J.Cancer R−es;85.1063(1994)) S.Kojimaほか、Biochim.Biophy−s.Acta;1381.312(1998) M.Matsukiほか、Radioisotopes 47.291(1998) K.Yamaokaほか、Free Radic.Bi−ol.Med;11.299(1991) S.Kojimaほか、Anticancer Res 18.2471(1998) K.Yamaokaほか、Biochim.Bioph−ys.Acta;1381.265(1998) Y.Takeharaほか、Physiol.Che−m.Phys.Med.NMR.27.149(1995) Mifune M,Sobue T,Arimoto H,Kokoto Y,Kondo S,Tanooka H;Jpn.J.Cancer Res.83.1−5(1992) Yonezawa M,Takeda A,Misonoh J;J.Radiat.Res.31.256−262(1991) Yonezawa M,Misonoh J,Hosokawa Y;Mutat,Res.358.237−243(1996) 山岡聖典著.「バードガスタインのラドン療法とその機構解明」.Radiosotope.47:729−730(1998)
Tourmaline has the property of storing ambient heat energy once and converting it into “far infrared rays” and radiating it, and its thermal energy conversion efficiency is 92.72% (far infrared wavelength 4 to 11 microns) and is known to be extremely high. Has been.
JP 2000-273033 A K. Yamaoka et al., Arch. Bikphys; 302.37 (1993) G. Bernatsky et al. Phys. Med. B-aln. Med. Klin; 19.36 (1990) M.M. Mifune et al., Jpn. J. et al. Cancer R-es; 83.1 (1992)) Y. Suzuki et al., Jpn. J. et al. Cancer R-es; 85.1063 (1994)) S. Kojima et al., Biochim. Biophy-s. Acta; 1381.312 (1998) M.M. Matsuki et al., Radioisotopes 47.291 (1998) K. Yamaoka et al., Free Radic. Bi-ol. Med; 11.299 (1991) S. Kojima et al., Anticancer Res 18.2471 (1998) K. Yamaoka et al., Biochim. Bioph-ys. Acta; 1382.265 (1998) Y. Takehara et al., Physiol. Che-m. Phys. Med. NMR. 27.149 (1995) Mifune M, Sobu T, Arimoto H, Kokoto Y, Kondo S, Tanoka H; Jpn. J. et al. Cancer Res. 83.1-5 (1992) Yonezawa M, Takeda A, Misonoh J; Radiat. Res. 31.256-262 (1991) Yonezawa M, Misonoh J, Hosokawa Y; Mutat, Res. 358.237-243 (1996) Authored by Yamaoka Seinori. “Birdgastein's radon therapy and its mechanism elucidation”. Radiotopope. 47: 729-730 (1998)

解決しようとする問題点は、日常生活において低線量放射線によるホルミシス効果を簡便、容易に獲得するための手法が開発されていない点である。  The problem to be solved is that a method for easily and easily acquiring the hormesis effect by low-dose radiation in daily life has not been developed.

本発明は、低線量放射線によるホルミシス効果を簡便、容易に活用するために低線量放射線を放射する希有ミネラル元素鉱物からなるセラミックの超微粉末を天然素材の水溶性高分子ゲルに配合して皮膚外用剤を開発したことを最も主要な特徴とする。  In order to easily and easily utilize the hormesis effect caused by low-dose radiation, the present invention blends a ceramic ultrafine powder made of a rare mineral element mineral that emits low-dose radiation into a water-soluble polymer gel made of natural material. The main feature is the development of an external preparation.

本発明の皮膚外用剤は、低線量放射線を放射する希有ミネラル元素鉱物の不純物を焼却するために高温下でセラミックを製成し、そのセラミックを2〜5ミクロンの微粉末にしたものを天然素材からなる水溶性高分子ゲルに配合するため、人体に対するホルミシス効果を簡便、且つ、容易に獲得できることを可能とするという利点がある。  The external preparation for skin of the present invention is a natural material obtained by forming a ceramic at a high temperature in order to incinerate impurities of a rare mineral element mineral that emits low-dose radiation, and converting the ceramic into a fine powder of 2 to 5 microns. Therefore, there is an advantage that the hormesis effect on the human body can be obtained easily and easily.

低線量放射線を放射する希有ミネラル元素鉱物の不純物を焼却するために高温下でセラミックを製成し、そのセラミックを2〜5ミクロンの微粉末にしたものと、電気石と呼ばれるトルマリンの超微粉末を天然素材からなる水溶性高分子ゲルに配合すると、人体に対するホルミシス効果を簡便、且つ容易に獲得できるという目的を、新規の手段として実現した。  To incinerate impurities of rare mineral elements that emit low-dose radiation, ceramics are produced under high temperature, and the ceramics are made into 2-5 micron fine powder, and tourmaline ultrafine powder called tourmaline When water is blended with a water-soluble polymer gel made of a natural material, the purpose of easily and easily obtaining the hormesis effect on the human body has been realized as a novel means.

本発明は、三朝温泉と同等の2000Bq/立法m濃度のラドン鉱石粉末30重量%を粘度粉に配合し、不純物を除去するために焼結してセラミック片を製作した。  In the present invention, a ceramic piece was prepared by blending 30% by weight of radon ore powder having a concentration of 2000 Bq / legitimate m, equivalent to Misasa Onsen, into a viscous powder and sintering to remove impurities.

このセラミック片を2〜5ミクロンの微粉末にし特開2000−273033号発明の天然素材からなる水溶性高分子ゲルに0.6%重量部、トルマリン微粉末0.5%重量部のほか、化粧品粧剤である1.3−ブチレングリコール、ハイソルブEPH、イノシトール、グリチノンK2、スエルチアニン、チンピリキッド、トウキリキッド、トウヒリキッドを配合し皮膚外用剤を開発した。  This ceramic piece is made into 2-5 micron fine powder, 0.6% by weight, 0.5% by weight of tourmaline fine powder and 0.5% by weight of tourmaline fine powder in the water-soluble polymer gel made of the natural material of JP2000-273033A. An external preparation for skin was formulated by blending the cosmetics 1.3-butylene glycol, Hisolv EPH, inositol, glycinone K2, swell cyanine, tingpilyd, toki liquid, and tohu liquid.

ホルミシス効果を簡便、容易に獲得することができる皮膚外用剤を開発したことから、筋肉の強ばりの改善などの効果に着目しリハビリテーションや運動障害の予防などにも適用できる。  Since an external preparation for skin that can easily and easily acquire the hormesis effect has been developed, it can be applied to rehabilitation and prevention of movement disorders, focusing on effects such as improving muscle strength.

Claims (7)

低線量の放射線を放射する稀有ミネラル元素鉱物を主原料としたセラミックの微粉末を配合した皮膚外用剤。  A topical skin preparation formulated with a fine ceramic powder made from a rare mineral element mineral that emits low-dose radiation. 低線量の放射線を放射する希有ミネラル元素鉱物がラジウム鉱石であることを特徴とする請求項1記載の皮膚外用剤。  The skin external preparation according to claim 1, wherein the rare mineral element mineral that emits a low dose of radiation is radium ore. 低線量の放射線を放射する希有ミネラル元素鉱物がラドンの希ガス元素を放射する鉱物であることを特徴とする請求項1から請求項2に記載の皮膚外用剤。  The skin external preparation according to claim 1 or 2, wherein the rare mineral element mineral that emits a low dose of radiation is a mineral that emits a rare gas element of radon. 電気石等の花崗岩鉱物の微粉末を配合したことを特徴とする請求項1から請求項3に記載の皮膚外用剤。  The external preparation for skin according to any one of claims 1 to 3, wherein fine powder of granite mineral such as tourmaline is blended. 少なくとも請求項1から請求項4に記載の2つ以上の鉱物からなるセラミックの微粉末を配合したことを特徴とする皮膚外用剤。  An external preparation for skin, comprising a ceramic fine powder comprising at least two or more minerals according to any one of claims 1 to 4. 一般に化粧品粧剤として使用される、例えば、タカラゲン、1.3−ブチレングリコール、ハイソルブEPH、イノシトール、チンピリキッド、ビタミンC、ビタミンEなどを配合した請求項1から請求項5記載の皮膚外用剤。  The external preparation for skin according to any one of claims 1 to 5, which is generally used as a cosmetic cosmetic, and contains, for example, Takaragen, 1.3-butylene glycol, Hisolv EPH, inositol, chinpyrid, vitamin C, vitamin E and the like. 請求項1から請求項6記載の皮膚外用剤が水溶性ゲルを溶剤としたことを特徴とする皮膚外用剤。  A skin external preparation, wherein the skin external preparation according to claim 1 uses a water-soluble gel as a solvent.
JP2003436788A 2003-12-21 2003-12-21 Skin preparation for external use Withdrawn JP2005179331A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003436788A JP2005179331A (en) 2003-12-21 2003-12-21 Skin preparation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003436788A JP2005179331A (en) 2003-12-21 2003-12-21 Skin preparation for external use

Publications (1)

Publication Number Publication Date
JP2005179331A true JP2005179331A (en) 2005-07-07

Family

ID=34791948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003436788A Withdrawn JP2005179331A (en) 2003-12-21 2003-12-21 Skin preparation for external use

Country Status (1)

Country Link
JP (1) JP2005179331A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297341A (en) * 2006-05-01 2007-11-15 Athletes:Kk Method for producing hairdressing material and hairdressing material
EP1878433A1 (en) * 2006-07-14 2008-01-16 Paolo Colombini Topical composition comprising magmatites
JP2009298780A (en) * 2008-06-17 2009-12-24 Sueam Co Ltd Massage cream
JP2017031116A (en) * 2015-08-04 2017-02-09 スイーム株式会社 Method of irradiating skin, and cream

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007297341A (en) * 2006-05-01 2007-11-15 Athletes:Kk Method for producing hairdressing material and hairdressing material
EP1878433A1 (en) * 2006-07-14 2008-01-16 Paolo Colombini Topical composition comprising magmatites
JP2009298780A (en) * 2008-06-17 2009-12-24 Sueam Co Ltd Massage cream
JP2017031116A (en) * 2015-08-04 2017-02-09 スイーム株式会社 Method of irradiating skin, and cream

Similar Documents

Publication Publication Date Title
Panhóca et al. Treatment of facial nerve palsies with laser and endermotherapy: a report of two cases
JP2005179331A (en) Skin preparation for external use
US10610699B2 (en) Therapeutic device using far-infrared radiation
CN104291794B (en) A kind of anionic particle material that can produce micro-electric current
CN104147701A (en) Electret static far infrared magnet therapy patch and preparation method thereof
Zhang et al. The effect of photoluminescence of bioceramic irradiation on middle cerebral arterial occlusion in rats
KR20160059416A (en) Micro current controller and conductive silicon sheet with the same
JP6383137B2 (en) Current supply device
CN107029358A (en) Far-infrared magnetic resonance physical therapy equipment
Ponomarenko Physical and rehabilitative medicine: fundamental principles and clinical practice
CN104594048A (en) Yarn comprising negative ion particles for producing microcurrent
CN104278543A (en) Dye comprising negative ion particles
TWM453511U (en) Structure of energy chip
CN100337703C (en) Method of improving efficacy and synsory tolerance with continuous pulse, non-modulated non-burst mode nerve stimulator
CN201847835U (en) Therapeutic patch
CN111449934A (en) Sand physiotherapy bag
CN111374820A (en) Ultra-long wave temperature control health care pad for dredging channels and collaterals and blood vessels
CN102354098A (en) Watch with energetic particles
JP5589232B2 (en) Health appliances
KR20160087723A (en) Hot Packs
JP2004337559A (en) Healthy tool made of ceramic using natural radioactive rare earth element mineral
CN1569039A (en) Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation
CN1813845A (en) Tourmaline multifunctional oint ment for promoting blood circulation and tranquilizing and its preparing method
CN105521564B (en) Neck therapeutic instrument for rehabilitation
Klamruen et al. Response to Letter to the Editor on" Effects of Anodal Transcranial Direct Current Stimulation With Overground Gait Training On Lower Limb Performance In Individuals With Incomplete Spinal Cord Injury"

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20070306